Why Auscap has gone from 7% cash to fully invested (and where that money has been deployed)
Is there value in the stock market today? It’s a broad and tricky question to answer, given the market comprises more than 2,000 individual companies. One measure of value is the cyclically adjusted price-to-earnings ratio (CAPE). By this metric, Tim Carleton from Auscap Asset Management says the local market looks reasonable value.
“As we sit here today, if you look at cyclically adjusted earnings and how they represent value, we’re sitting below the 40-year average," says Carleton
The ASX200 has experienced a ~10 per cent sell-off from the recent highs in February to the low in late October as rising bond yields forced investors to adjust their valuations.
According to Carleton, the result is that value has emerged in sectors of the ASX that benefited from the low-interest rates environment, such as healthcare, infrastructure and technology.
Carleton explains that his fund was holding as much as 7% cash but is now fully invested due to the compelling valuations the recent sell-off created.
In the full interview, Carleton discusses why Australian equities look reasonable value, his long-term view on lithium and the earnings outlook for Resmed.
Key points
- 0:00 - Intro
- 0:17 - Which parts of the ASX look attractive?
- 0:56 - Valuations in shares versus other asset classes
- 2:51 - Is there a risk of further earnings shocks?
- 3:55 - Why Auscap is fully invested
- 4:38 - Two stocks that can deliver long term compound earnings growth
- 5:47 - Emerging value in lithium stocks
- 10:45 - Why Resmed (ASX:RMD) shares have fallen
- 13:49 - The earnings outlook for Resmed (ASX: RMD)
Introducing the Auscap Ex-20 Australian Equities Fund
Auscap Asset Management is launching a new fund that will invest in companies outside the ASX20.
For more information please visit the Auscap Asset Management website.
2 topics
2 stocks mentioned
1 contributor mentioned